Although children and teens generally show milder symptoms of COVID-19, they are not immune to the SARS-CoV-2 virus. Meridian is now enrolling children age 6 months to 11 years for a COVID-19 vaccine study. Eligible participants will receive an investigational COVID-19 vaccine as part of this study.
Eligible participants…
- Must be age 6 months to 11 years
- Cannot have had SARS-CoV-2 infection (COVID-19), nor a COVID-19 vaccine or booster
- Must not have a history of autoimmune disease or an active autoimmune disease
- Will receive compensation for study-related time
- May also be provided with transportation assistance on a case-by-case basis, as needed
- Do not need insurance to join this study
For more information, complete the form on this page. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. There is no obligation to join — you can decide if the study is right for your child.
You can also talk to a Meridian enrollment specialist about this study by calling (712) 639-6200.

Submit your information
Study Location
Meridian Clinical Research
6940 Van Dorn Street, Suite #201
Lincoln, NE 68506
Founded in 1999 in Omaha, NE, Meridian studies the safety and effectiveness of new medicines, devices, and treatments. Its mission is to enrich lives by providing quality, compassionate care to patients and unparalleled clinical research services. Clinical studies help scientists develop life-changing medicines, but it starts with you — participation makes it all possible. For more than 20 years, thousands of patients have trusted Meridian because of our focus on creating a positive patient experience.
© 2022 MERIDIAN CLINICAL RESEARCH, LLC | Privacy Policy